RNA interference targeting NRP-1 inhibits human glioma cell proliferation and enhances cell apoptosis

Molecular Medicine Reports

Volumn 4, Issue 6, 2011, Pages 1261-1266

  Li, Xiangyun ^a   Tang, Ting ^a   Lu, Xiaozhe ^a   Zhou, Houguang ^a   Huang, Yanyan ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Glioma; Mitogen activated protein kinase; Neuropilin 1; Proliferation; Rna interference

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; NEUROPILIN 1; PROTEIN BCL 2; STRESS ACTIVATED PROTEIN KINASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL LINE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; ENZYME INACTIVATION; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; RNA INTERFERENCE; TUMOR GROWTH; WESTERN BLOTTING;

APOPTOSIS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; G1 PHASE CELL CYCLE CHECKPOINTS; GLIOMA; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; NEUROPILIN-1; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA INTERFERENCE; RNA, SMALL INTERFERING; S PHASE CELL CYCLE CHECKPOINTS;

EID: 80053104790     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.550     Document Type: Article

References (24)

1. Cui G, Li Z, Shao B, et al: Clinical and biological significance of nemo-like kinase expression in glioma. J Clin Neurosci 18: 271-275, 2011.
2. Jadus MR, Chen Y, Boldaji MT, et al: Human U251MG glioma cells expressing the membrane form of macrophage colony-stimulating factor (mM-CSF) are killed by human monocytes in vitro and are rejected within immunodeficient mice via paraptosis that is associated with increased expression of three different heat shock proteins. Cancer Gene Ther 10: 411-420, 2003. (Pubitemid 36528785)
3. Parney IF, Hao C and Petruk KC: Glioma immunology and immunotherapy. Neurosurgery 46: 778-791; discussion 791-772, 2000.
4. Enloe BM and Jay DG: Inhibition of Necl-5 (CD155/PVR) reduces glioblastoma dispersal and decreases MMP-2 expression and activity. J Neurooncol 102: 225-235, 2011.
5. Furnari FB, Fenton T, Bachoo RM, et al: Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21: 2683-2710, 2007. (Pubitemid 350070717)
6. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. Ca Cancer J Clin 61: 69-90, 2011.
7. Joy AM, Beaudry CE, Tran NL, et al: Migrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosis. J Cell Sci 116: 4409-4417, 2003. (Pubitemid 37369596)
8. Cho SY and Klemke RL: Extracellular-regulated kinase activation and CAS/Crk coupling regulate cell migration and suppress apoptosis during invasion of the extracellular matrix. J Cell Biol 149: 223-236, 2000. (Pubitemid 30196711)
9. Hong TM, Chen YL, Wu YY, et al: Targeting neuropilin 1 as an antitumor strategy in lung cancer. Clinical Cancer Research 13: 4759-4768, 2007.
10. Karjalainen K, Jaalouk DE, Bueso-Ramos CE, et al: Targeting neuropilin-1 in human leukemia and lymphoma. Blood 117: 920-927, 2011.
11. Jia H, Cheng L, Tickner M, Bagherzadeh A, Selwood D and Zachary I: Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity. Brit J Cancer 102: 541-552, 2010.
12. Lee P, Goishi K, Davidson AJ, Mannix R, Zon L and Klagsbrun M: Neuropilin-1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafish. Proc Natl Acad Sci USA 99: 10470-10475, 2002.
13. Pan Q, Chanthery Y, Liang WC, et al: Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth. Cancer Cell 11: 53-67, 2007. (Pubitemid 46054517)
14. Wey JS, Gray MJ, Fan F, et al: Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells. Brit J Cancer 93: 233-241, 2005. (Pubitemid 41133210)
15. Kaabinejadian S, Fouladdel S, Ramezani M and Azizi E: Molecular analysis of Bcl-2 and cyclin D1 expression in differentially expressing estrogen receptor breast cancer MCF7, T47D and MDA-MB-468 cell lines treated with adriamycin. Daru 16: 182-188, 2008.
16. Yu CF, Minemoto Y, Zhang JY, et al: JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD. Mol Cell 13: 329-340, 2004. (Pubitemid 38229806)
17. Davidson B, Konstantinovsky S, Kleinberg L, et al: The mitogen-activated protein kinases (MAPK) p38 and JNK are markers of tumor progression in breast carcinoma. Gynecol Oncol 102: 453-461, 2006. (Pubitemid 44376656)
18. Fukazawa H, Noguchi K, Murakami Y and Uehara Y: Mitogen--activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitors restore anoikis sensitivity in human breast cancer cell lines with a constitutively activated extracellular-regulated kinase (ERK) pathway. Mol Cancer Ther 1: 303-309, 2002.
19. Yu JH, Wang HJ, Li XR, Tashiro SI, Onodera S and Ikejima T: Protein tyrosine kinase, JNK, and ERK involvement in pseudolaric acid B-induced apoptosis of human breast cancer MCF-7 cells. Acta Pharmacol Sin 29: 1069-1076, 2008.
20. Ryazantseva NV, Novitsky VV, Chasovskih NY, et al: Role of recombinant mitogen-activated protein kinases JNK and p38 in the regulation of apoptosis in blood mononuclear cells under conditions of oxidative stress in vitro. Bull Exp Biol Med 145: 569-572, 2008.
21. Subauste MC, Pertz O, Adamson ED, Turner CE, Junger S and Hahn KM: Vinculin modulation of paxillin-FAK interactions regulates ERK to control survival and motility. J Cell Biol 165: 371-381, 2004. (Pubitemid 38649912)
22. Raskopf E, Vogt A, Standop J, Sauerbruch T and Schmitz V: Inhibition of neuropilin-1 by RNA-interference and its angiostatic potential in the treatment of hepatocellular carcinoma. Z Gastroenterol 48: 21-27, 2010.
23. Robinson CJ and Stringer SE: The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci 114: 853-865, 2001. (Pubitemid 32273121)
24. Wada T and Penninger JM: Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23: 2838-2849, 2004. (Pubitemid 38638846)